Healthcare entity
Alfred Ford Jr. is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. That works out to roughly 1.6 stories per week across a 9-day span. The clearest coverage concentration is market-trends: 1 of 2 stories, with the rest divided among 1 other category.
Last mentioned: Aug 24, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Alfred Ford Jr. is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. That works out to roughly 1.6 stories per week across a 9-day span. The clearest coverage concentration is market-trends: 1 of 2 stories, with the rest divided among 1 other category. The 5 average consequence score is below the beat benchmark of 5.4 in the same window. Each story carries 2 original sources on average, compared with 2.3 for the broader beat in this window. BTIG Research appears in 2 tracked Healthcare stories published from August 4, 2026 through August 12, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 126 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering BTIG Research. Shared-story counts are live from our verified record — not editorial picks.
Timothy Moran sells 2,380 shares
Average price of $23.76 for $56,548.80; stake falls 3.46% to 66,345 shares. Sale to cover tax withholding obligations.
KMTS stock rises
Shares trade up $1.16 to $23.99 with 373,728 shares of volume versus a 404,856 average.
Alfred Ford Jr. sells 8,681 shares
Average price of $22.61 for $196,277.41; stake falls 6.81% to 118,854 shares. Sale to cover tax withholding obligations.
Kestra reports quarterly earnings
Revenue of $28.64 million; EPS of -$0.67 missed consensus of -$0.59. Analysts forecast full-year EPS of -$2.29.
Two Kestra Medical Technologies insiders disclosed routine tax-withholding sales totaling 11,061 shares after a July earnings report that missed consensus. The transactions highlight equity-vesting mechanics, but the company's negative margins and projected losses are a more consequential signal for healthcare partners assessing vendor sustainability.
Source: dailypolitical.com · tickerreport.com
Wall Street Zen downgraded vaccine maker Novavax to sell, raising alarms in the healthcare sector. The stock traded at $7.41, far below its $13 consensus target, with a negative P/E of -12.78.
BTIG Research is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
